Skip to main content

Table 3 Logistic regression model comparing 12 end-of-life care outcomes for three age groups (in years) and for men and women, adjusted for place of death (hospital/nursing home). Odds ratios (OR) and 95% confidence intervals (CI) are reported

From: Better quality of end-of-life care for persons with advanced dementia in nursing homes compared to hospitals: a Swedish national register study

  n % OR 95% CI p
PRN drugs against pain
 Age
  41–64 88/95 92.6 1.006 0.464–2.185 0.987
  65–84 4799/5086 94.4 1.335 1.159–1.537 < 0.001
  85–110 10,413/11,219 92.8 Refa
 Gender
  Women 10,342/11,081 93.3 1.006 0.880–1.149 0.931
  Men 4958/5319 93.2 Refa
PRN drugs against nausea
 Age
  41–64 59/94 62.8 1.108 0.726–1.691 0.636
  65–84 3131/5037 62.2 1.069 0.997–1.147 0.060
  85–110 6814/11,106 61.4 Refa
 Gender
  Women 6832/10,984 62.2 1.038 0.969–1.113 0.285
  Men 3172/5253 60.4 Refa
PRN drugs against anxiety
 Age
  41–64 79/94 84.0 0.991 0.568–1.730 0.975
  65–84 4342/5063 85.8 1.127 1.024–1.240 0.014
  85–110 9455/11,172 84.6 Refa
 Gender
  Women 9405/11,041 85.2 1.017 0.926–1.116 0.728
  Men 4471/5288 84.5 Refa
Pain assessed and documented during the last week of life
 Age
  41–64 29/93 31.2 1.025 0.658–1.595 0.914
  65–84 1550/4916 31.5 1.039 0.965–1.118 0.313
  85–110 3399/10,834 31.4 Refa
 Gender
  Women 3428/10,726 32.0 1.042 0.968–1.121 0.277
  Men 1550/5117 30.3 Refa
Symptoms other than pain assessed during the last week of life
 Age
  41–64 22/87 25.3 1.572 0.966–2.560 0.069
  65–84 890/4830 18.4 1.049 0.960–1.146 0.294
  85–110 1940/10,692 18.1 Refa
 Gender
  Women 1984/10,584 18.7 1.080 0.988–1.181 0.091
  Men 868/5025 17.3 Refa
Oral health assessed during the last week of life
 Age
  41–64 78/93 83.9 1.712 0.983–2.981 0.058
  65–84 3696/4730 78.1 1.162 1.069–1.263 < 0.001
  85–110 7848/10,359 75.8 Refa
 Gender
  Women 7923/10,286 77.0 1.112 1.025–1.206 0.010
  Men 3699/4896 75.6 Refa
Next of kin informed about transition to end-of-life care
 Age
  41–64 72/90 80.0 1.630 0.970–2.739 0.065
  65–84 3549/4733 75.0 1.224 1.131–1.325 < 0.001
  85–110 7308/10,355 70.6 Refa
 Gender
  Women 7331/10,274 71.4 0.959 0.887–1.036 0.289
  Men 3598/4904 73.4 Refa
Next of kin offered a follow-up talk after death of the patient
 Age
  41–64 69/84 82.1 1.776 1.005–3.140 0.048
  65–84 3119/4152 75.1 1.161 1.064–1.265 0.001
  85–110 6772/9258 73.1 Refa
 Gender
  Women 6828/9217 74.1 0.983 0.903–1.071 0.701
  Men 3132/4277 73.2 Refa
Documented decision to shift to end-of-life care
 Age
  41–64 75/84 89.3 1.066 0.531–2.141 0.858
  65–84 4145/4574 90.6 1.216 1.079–1.371 0.001
  85–110 8971/10,050 89.3 Refa
 Gender
  Women 8934/9924 90.0 1.083 0.966–1.215 0.171
  Men 4257/4784 89.0 Refa
Specialised palliative care team consulted
 Age
  41–64 3/95 3.2 2.895 0.902–9.293 0.074
  65–84 84/5112 1.6 1.461 1.103–1.937 0.008
  85–110 127/11,255 1.1 Refa
 Gender
  Women 147/11,120 1.3 1.181 0.877–1.590 0.274
  Men 67/5342 1.3 Refa
Someone present at the moment of death
 Age
  41–64 85/93 91.4 1.505 0.720–3.147 0.277
  65–84 4554/5043 90.3 1.340 1.197–1.501 < 0.001
  85–110 9724/11,035 88.1 Refa
 Gender
  Women 9691/10,915 88.8 0.904 0.811–1.008 0.070
  Men 4672/5256 88.9 Refa
Pressure ulcers at death
 Age
  41–64 13/94 13.8 0.829 0.460–1.496 0.534
  65–84 767/5055 15.2 0.943 0.859–1.036 0.221
  85–110 1717/11,156 15.4 Refa
 Gender
  Women 1613/11,031 14.6 0.876 0.799–0.960 0.005
  Men 884/5274 16.8 Refa
  1. a Reference